| Source | us.nlm.vsac#0.11.0:null (v4.0.1) |
| resourceType | ValueSet |
| id | 2.16.840.1.113883.3.464.1003.110.12.1042 |
| canonical | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.12.1042 |
| version | 20220909 |
| status | active |
| publisher | NCQA PHEMUR |
| name | HepatitisBVaccineAdministered |
| title | Hepatitis B Vaccine Administered |
| date | 2022-09-09T01:02:41-04:00 |
| experimental | false |
| Usages | (none) |
This value set contains 27 concepts
| Code | System | Display |
| 1162640003 | http://snomed.info/sct | Administration of vaccine product containing only acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Hepatitis B virus and inactivated Human poliovirus antigens (procedure) |
| 16584000 | http://snomed.info/sct | Administration of vaccine product containing only Hepatitis B virus antigen (procedure) |
| 170370000 | http://snomed.info/sct | Administration of first dose of vaccine product containing only Hepatitis B virus antigen (procedure) |
| 170371001 | http://snomed.info/sct | Administration of second dose of vaccine product containing only Hepatitis B virus antigen (procedure) |
| 170372008 | http://snomed.info/sct | Administration of third dose of vaccine product containing only Hepatitis B virus antigen (procedure) |
| 170373003 | http://snomed.info/sct | Administration of booster dose of vaccine product containing only Hepatitis B virus antigen (procedure) |
| 170374009 | http://snomed.info/sct | Administration of fourth dose of vaccine product containing only Hepatitis B virus antigen (procedure) |
| 170375005 | http://snomed.info/sct | Administration of fifth dose of vaccine product containing only Hepatitis B virus antigen (procedure) |
| 170434002 | http://snomed.info/sct | Administration of first dose of vaccine product containing only Hepatitis A and Hepatitis B virus antigens (procedure) |
| 170435001 | http://snomed.info/sct | Administration of second dose of vaccine product containing only Hepatitis A and B virus antigens (procedure) |
| 170436000 | http://snomed.info/sct | Administration of third dose of vaccine product containing only Hepatitis A and Hepatitis B virus antigens (procedure) |
| 170437009 | http://snomed.info/sct | Administration of booster dose of vaccine product containing only Hepatitis A and Hepatitis B virus antigens (procedure) |
| 312868009 | http://snomed.info/sct | Administration of vaccine product containing only Hepatitis A and Hepatitis B virus antigens (procedure) |
| 396456003 | http://snomed.info/sct | Administration of vaccine product containing only acellular Bordetella pertussis and Corynebacterium diphtheriae and Hepatitis B virus and inactivated whole Human poliovirus antigens (procedure) |
| 416923003 | http://snomed.info/sct | Administration of sixth dose of vaccine product containing only Hepatitis B virus antigen (procedure) |
| 572561000119108 | http://snomed.info/sct | Administration of vaccine product containing only acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Hepatitis B virus and inactivated whole Human poliovirus antigens (procedure) |
| 770608009 | http://snomed.info/sct | Administration of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Hepatitis B virus antigens (procedure) |
| 770616000 | http://snomed.info/sct | Administration of first dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Hepatitis B virus antigens (procedure) |
| 770617009 | http://snomed.info/sct | Administration of second dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Hepatitis B virus antigens (procedure) |
| 770618004 | http://snomed.info/sct | Administration of third dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Hepatitis B virus antigens (procedure) |
| 786846001 | http://snomed.info/sct | Administration of vaccine product containing only Haemophilus influenzae type b and Hepatitis B virus antigens (procedure) |
| 90697 | http://www.ama-assn.org/go/cpt | Diphtheria, tetanus toxoids, acellular pertussis vaccine, inactivated poliovirus vaccine, Haemophilus influenzae type b PRP-OMP conjugate vaccine, and hepatitis B vaccine (DTaP-IPV-Hib-HepB), for intramuscular use |
| 90723 | http://www.ama-assn.org/go/cpt | Diphtheria, tetanus toxoids, acellular pertussis vaccine, hepatitis B, and inactivated poliovirus vaccine (DTaP-HepB-IPV), for intramuscular use |
| 90740 | http://www.ama-assn.org/go/cpt | Hepatitis B vaccine (HepB), dialysis or immunosuppressed patient dosage, 3 dose schedule, for intramuscular use |
| 90744 | http://www.ama-assn.org/go/cpt | Hepatitis B vaccine (HepB), pediatric/adolescent dosage, 3 dose schedule, for intramuscular use |
| 90747 | http://www.ama-assn.org/go/cpt | Hepatitis B vaccine (HepB), dialysis or immunosuppressed patient dosage, 4 dose schedule, for intramuscular use |
| 90748 | http://www.ama-assn.org/go/cpt | Hepatitis B and Haemophilus influenzae type b vaccine (Hib-HepB), for intramuscular use |
Produced 08 Sep 2023